Medpace Holdings, Inc. (MEDP): Price and Financial Metrics


Medpace Holdings, Inc. (MEDP)

Today's Latest Price: $134.41 USD

2.39 (1.81%)

Updated Jan 28 11:18am

Add MEDP to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 78 in Medical - Services

See all "A" rated Strong Buy stocks

MEDP Stock Summary

  • MEDP's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 165.8 -- higher than 80.78% of US-listed equities with positive expected earnings growth.
  • Medpace Holdings Inc's stock had its IPO on August 11, 2016, making it an older stock than just 15.64% of US equities in our set.
  • With a year-over-year growth in debt of 140.47%, Medpace Holdings Inc's debt growth rate surpasses 90.9% of about US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Medpace Holdings Inc are HCKT, PIPR, III, HLI, and CNS.
  • MEDP's SEC filings can be seen here. And to visit Medpace Holdings Inc's official web site, go to www.medpace.com.

MEDP Stock Price Chart Interactive Chart >

Price chart for MEDP

MEDP Price/Volume Stats

Current price $134.41 52-week high $150.57
Prev. close $132.02 52-week low $58.72
Day low $132.08 Volume 22,194
Day high $134.73 Avg. volume 183,563
50-day MA $136.15 Dividend yield N/A
200-day MA $113.22 Market Cap 4.81B

Medpace Holdings, Inc. (MEDP) Company Bio


Medpace, Inc. operates as a contract research organization that provides research based drug and medical device development services. The company was founded in 1992 and is based in Cincinnati, Ohio.

MEDP Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$134.41$88.35 -33%

Below please find a table outlining a discounted cash flow forecast for MEDP, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Medpace Holdings Inc ranked in the 41th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. As for the metrics that stood out in our discounted cash flow analysis of Medpace Holdings Inc, consider:

  • The stock's equity weight, or the proportion of capital from equity relative to debt, is 98. Notably, its equity weight is greater than 81.8% of US equities in the Healthcare sector yielding a positive free cash flow.
  • The business' balance sheet suggests that 2% of the company's capital is sourced from debt; this is greater than only 10.73% of the free cash flow producing stocks we're observing.
  • Medpace Holdings Inc's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at -206.25. This coverage rate is greater than that of only 1.24% of stocks we're observing for the purpose of forecasting via discounted cash flows.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-34%
1%-34%
2%-33%
3%-32%
4%-32%
5%-31%

QDEL, STE, AMGN, INBP, and NVS can be thought of as valuation peers to MEDP, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.


MEDP Latest News Stream


Event/Time News Detail
Loading, please wait...

MEDP Latest Social Stream


Loading social stream, please wait...

View Full MEDP Social Stream

Latest MEDP News From Around the Web

Below are the latest news stories about Medpace Holdings Inc that investors may wish to consider to help them evaluate MEDP as an investment opportunity.

Contract Research Organization Market to Witness Huge Growth by 2024| Key Players are IQVIA Holdings, Inc., Laboratory Corporation of America Holdings, Syneos Health Inc, PRA Health Sciences, Medpace Holdings Inc and Wuxi AppTec Co Ltd

ReportsnReports.com the exclusive leading provider of market research reports published research report on “China Contract Research Organization (CRO) Market (Clinical, Pre-clinical & Discovery): Insights, Trends and Forecast (2020-2024)”. China CRO market value is anticipated to reach US$27.04 billion in 2024, growing

OpenPR | January 11, 2021

Insider Selling: Medpace Holdings, Inc. (NASDAQ:MEDP) CEO Sells 185,219 Shares of Stock

Medpace Holdings, Inc. (NASDAQ:MEDP) CEO August J. Troendle sold 185,219 shares of the firm’s stock in a transaction dated Thursday, January 7th. The shares were sold at an average price of $140.06, for a total transaction of $25,941,773.14. NASDAQ:MEDP traded up $1.86 during midday trading on Friday, hitting $141.76. 184,940 shares of the stock were […]

Watchlist News | January 8, 2021

Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2020 Financial Results on February 15, 2021

CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its fourth quarter and fiscal year 2020 financial results after the market close on Monday, February 15, 2021. The Company will host a conference call the following morning, Tuesday, February 16, 2021, at 9:00 a.m. ET to discuss these results. To participate in the conference call, dial 800-219-7113 (domestic) or 574-990-1030 (international) using the passcode 9646903. To access th

Business Wire | January 5, 2021

Insider Selling: Medpace Holdings, Inc. (NASDAQ:MEDP) CEO Sells $496,970.17 in Stock

Medpace Holdings, Inc. (NASDAQ:MEDP) CEO August J. Troendle sold 3,547 shares of the firm’s stock in a transaction on Wednesday, December 23rd. The shares were sold at an average price of $140.11, for a total transaction of $496,970.17. Following the completion of the sale, the chief executive officer now owns 706,643 shares in the company, […]

Watchlist News | January 1, 2021

Is MEDP A Good Stock To Buy Now?

The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the third quarter, which unveil their equity positions as of September 30. We went through these filings, fixed typos and other more significant errors and identified the changes in hedge fund portfolios. Our extensive […]

Yahoo | December 20, 2020

Read More 'MEDP' Stories Here

MEDP Price Returns

1-mo -2.51%
3-mo 21.16%
6-mo 12.62%
1-year 51.82%
3-year 246.51%
5-year N/A
YTD -3.44%
2020 65.60%
2019 58.81%
2018 45.97%
2017 0.53%
2016 N/A

Continue Researching MEDP

Here are a few links from around the web to help you further your research on Medpace Holdings Inc's stock as an investment opportunity:

Medpace Holdings Inc (MEDP) Stock Price | Nasdaq
Medpace Holdings Inc (MEDP) Stock Quote, History and News - Yahoo Finance
Medpace Holdings Inc (MEDP) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.9198 seconds.